Congress - Cambridge MA, USA
Following the successful first Congress in Amsterdam, The Netherlands in 2010, the 2nd Antivirals Congress will be organized 11-13 November 2012 in Cambridge MA, USA. The key objectives of this interdisciplinary and unique congress are:
•To provide a state-of-the-art report for scientists, health professionals and (non)governmental authorities
•To accelerate progress in the development and application of antivirals: small molecules and biologics
•To serve as an interface between different interest groups from academia, those in research and development, regulatory and governmental agencies, charities, and health and industry professionals
The Congress will be supported by Antiviral Research, the most comprehensive and pre-eminent journal for those interested in the effective control of virus infections in animals and man as well as in plants or lower organisms.
Topics:
•Antivirals – Biodefence and emerging viruses
•Antivirals – Hepatitis
•Antivirals – HIV and other retroviruses
•Antivirals – Influenza
•Antivirals – Other
•Antiviral resistance
•Clinical trials and field studies
•Host-Virus interactions
•Immunology / Animal models
•Production / Manufacturing / Safety / Societal / Regulatory / Legislation aspects
http://www.antivirals.elsevier.com/index.html
Sun, Nov 11, 2012 - Tue, Nov 13, 2012
Boston Mariott
Two Cambridge Center, 50 Broadway, Massachusetts 02142 USA , United States
If you'd like to ask a question or post a comment about this talk please do so below.
This seminar posting is brought to you by Biotechnology Calendar, Inc. providing access to research information and research tools for nearly 20 years. Visit our Science Market Update Blog for current science funding and market information or see our schedule of upcoming science research laboratory product shows.
